Tower Research Capital (TRC)’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $119K | Sell |
|
|||||
|
2025
Q2 | $367K | Buy |
|
|||||
|
2025
Q1 | $17.9K | Sell |
|
|||||
|
2024
Q4 | $379K | Buy |
|
|||||
|
2024
Q3 | $23.1K | Sell |
|
|||||
|
2024
Q2 | $576K | Buy |
|
|||||
|
2024
Q1 | $26.9K | Sell |
|
|||||
|
2023
Q4 | $128K | Buy |
|
|||||
|
2023
Q3 | $46.5K | Sell |
|
|||||
|
2023
Q2 | $81.9K | Buy |
|
|||||
|
2023
Q1 | $31K | Buy |
|
|||||
|
2022
Q4 | $17K | Sell |
|
|||||
|
2022
Q3 | $200K | Buy |
|
|||||
|
2022
Q2 | $84K | Sell |
|
|||||
|
2022
Q1 | $368K | Buy |
|
|||||
|
2021
Q4 | $100K | Sell |
|
|||||
|
2021
Q3 | $79K | Buy |
|
|||||
|
2021
Q2 | $36K | Buy |
|
|||||
|
2021
Q1 | $10K | Sell |
|
|||||
|
2020
Q4 | $86K | Sell |
|
|||||
|
2020
Q3 | $359K | Buy |
|
|||||
|
2020
Q2 | $58K | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $40K | Buy |
|
|||||
|
2019
Q2 | $12K | Sell |
|
|||||
|
2019
Q1 | $24K | Sell |
|
|||||
|
2018
Q4 | $54K | Buy |
|